Alvotech ALVO
NASDAQ ALVO
$4.26 +0.27 (+6.77%)
As of: Aug 20, 2026 · 3:59 PM EDT

Alvotech (ALVO) Cash from Investing Activities (2022 - 2026)

Alvotech's (ALVO) quarterly Cash from Investing Activities came in at -$46.2 million in Q1 2026, down 126.5% YoY from $174.3 million in Q1 2025, and down 193.0% on a QoQ basis from -$15.8 million in Q4 2025.

Alvotech (ALVO) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has 5 years of Cash from Investing Activities data on file, last reported at -$46.2 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 126.5% year-over-year to -$46.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$130.0 million (down 450.93% YoY) and the FY2025 annual result came in at -$104.2 million, down 452.34% from the prior year.
  • Cash from Investing Activities retreated to -$46.2 million in Q1 2026, from -$15.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $22.8 million in Q3 2024 to a low of -$63.5 million in Q4 2022.
  • A 5-year average of -$22.5 million and a median of -$18.9 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Investing Activities jumped 74.92% — and 2025, when it tumbled 486.06%.
  • Tracing ALVO's Cash from Investing Activities over 5 years: stood at -$63.5 million in 2022, then advanced by 27.07% to -$46.3 million in 2023, then soared by 59.28% to -$18.9 million in 2024, then gained by 16.44% to -$15.8 million in 2025, then plunged by 193.0% to -$46.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$46.2 million (Q1 2026), -$15.8 million (Q4 2025), and -$39.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alvotech 1.26 Bn 1.26 Bn 5.09 Mn -46.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -46.20 Mn
Mar 31, 2026 -46.20 Mn
Dec 31, 2025 -15.77 Mn
Dec 31, 2025 -15.77 Mn
Sep 30, 2025 -39.45 Mn
Sep 30, 2025 -39.45 Mn
Jun 30, 2025 -28.60 Mn
Jun 30, 2025 -28.60 Mn
Mar 31, 2025 -20.40 Mn
Mar 31, 2025 -20.40 Mn
Dec 31, 2024 -18.87 Mn
Dec 31, 2024 -18.87 Mn
Sep 30, 2024 22.75 Mn
Sep 30, 2024 22.75 Mn
Jun 30, 2024 -7.09 Mn
Jun 30, 2024 -7.09 Mn
Mar 31, 2024 -3.48 Mn
Mar 31, 2024 -3.48 Mn
Dec 31, 2023 -46.34 Mn
Dec 31, 2023 -46.34 Mn